Benazepril Hydrochloride and Hydrochlorothiazide (H.J. Harkins Company, Inc.)
Welcome to the PulseAid listing for the Benazepril Hydrochloride and Hydrochlorothiazide drug offered from H.J. Harkins Company, Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | H.J. Harkins Company, Inc. |
NON-PROPRIETARY NAME: | Benazepril Hydrochloride and Hydrochlorothiazide |
SUBSTANCE NAME: | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2004-02-11 |
END MARKETING DATE: | 0000-00-00 |
Benazepril Hydrochloride and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
Item Description | Benazepril Hydrochloride and Hydrochlorothiazide from H.J. Harkins Company, Inc. |
LABELER NAME: | H.J. Harkins Company, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10; 12.5(mg/1; mg/1) |
START MARKETING DATE: | 2004-02-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52959-595_db7aec8b-4f85-4358-ba86-b5cbffb6a986 |
PRODUCT NDC: | 52959-595 |
APPLICATION NUMBER: | ANDA076631 |
Other BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers: